지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한정신약물학회 Clinical Psychopharmacology and Neuroscience Clinical Psychopharmacology and Neuroscience Vol.22 No.1
- 발행연도
- 2024.2
- 수록면
- 159 - 168 (10page)
- DOI
- 10.9758/cpn.23.1097
이용수
초록· 키워드
오류제보하기
Objective: Treatment Resistant Depression (TRD) is commonly defined as the lack of response to two or more anti depressants with different mechanisms of action. Up to 30% of patients diagnosed with major depressive disorder might be considered to present TRD. The objective of this study was to assess the effectiveness and tolerability of esketamine in patients diagnosed with TRD, who were referred to our program after exhausting all available treatments. A secondary objective consisted in researching the relationship between response and previous use of electroconvulsive therapy.
Methods: A prospective, observational study was carried out in patients enrolled in the expanded use of esketamine in our center. They received esketamine prior to its marketing authorisation, for therapeutic purposes. Sixteen subjects were analyzed. Effectiveness was assessed with the Montgomery-Asberg depression rating scale (MADRS). Patients were followed up to 4 months after the administration.
Results: Esketamine showed a rapid, robust effect in improving depressive symptoms, with no specific correlation be tween outcome and any demographic or clinical traits evaluated. No differences were found between patients that previously received Electroconvulsive Therapy, and those that didn’t. 10 out of 16 patients responded (＞ 50% change in baseline MADRS scores), but only five achieved remission (＜ 12 points in the global MADRS score). We provide some recommendations, based on clinical experience, to improve tolerability and adherence, and to manage adverse effects.
Conclusion: Results suggest that esketamine is a safe, effective and rapid-acting option for TRD. More studies are needed to properly assess predictors of response outcome.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis
Clinical Psychopharmacology and Neuroscience
2021 .01
-
Long-term Safety and Efficacy of Esketamine Nasal Spray Plus an Oral Antidepressant in Patients with Treatment-resistant Depression? an Asian Sub-group Analysis from the SUSTAIN-2 Study
Clinical Psychopharmacology and Neuroscience
2022 .02
-
치료저항성 우울증의 연구에서 패러다임의 전환
생물정신의학
2016 .01
-
Abnormal Prefrontal Brain Activation During a Verbal Fluency Task in Treatment-Resistant Depression Using Near-Infrared Spectroscopy
PSYCHIATRY INVESTIGATION
2023 .02
-
케타민의 항우울 효과와 임상적 적용
생물치료정신의학
2020 .06
-
주요우울장애 노인에 대한 Internet of Things 기반 행동 중재 : 예비연구
노인정신의학
2019 .01
-
A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
Clinical Psychopharmacology and Neuroscience
2021 .01
-
Neurofeedback Treatment on Depressive Symptoms and Functional Recovery in Treatment-Resistant Patients with Major Depressive Disorder: an Open-Label Pilot Study
Journal of Korean Medical Science
2019 .01
-
노년기 우울 증상 평가에서 주관적 척도와 객관적 척도 간 상관성 연구
노인정신의학
2023 .04
-
Treatment-Resistant Depression Entering Remission Following a Seizure during the Course of Repetitive Transcranial Magnetic Stimulation
PSYCHIATRY INVESTIGATION
2016 .01
-
The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study
Clinical Psychopharmacology and Neuroscience
2019 .01
-
Efficacy and Tolerability of Generic Mirtazapine (Mirtax) for Major Depressive Disorder: Multicenter, Open-label, Uncontrolled, Prospective Study
Clinical Psychopharmacology and Neuroscience
2015 .01
-
치료저항성 주요우울장애 환자의 광치료 증례
신경정신의학
2015 .01
-
전기경련치료에 대한 환자의 만족도 조사
신경정신의학
2021 .01
-
Predictors of Remission in Acute and Continuation Treatment of Depressive Disorders
Clinical Psychopharmacology and Neuroscience
2021 .08
-
Effect of Home-based Self-administered Transcranial Direct Stimulation in Patients with Mild to Moderate Major Depressive Disorder: A Single-arm, Multicentral Trial
Clinical Psychopharmacology and Neuroscience
2023 .05
-
Prevalence of Depressive Disorder of Outpatients Visiting Two Primary Care Settings
예방의학회지
2015 .01
-
Clinical Significance of the Number of Depressive Symptoms in Major Depressive Disorder: Results from the CRESCEND Study
Journal of Korean Medical Science
2016 .01
-
가상현실기법을 활용한 정신건강교육 및 기술훈련 프로그램의 우울증상 회복 및 자살위험성 감소 효과
신경정신의학
2020 .01
-
Evidence-Based Treatment for Depressive Disorder
PSYCHIATRY INVESTIGATION
2015 .01
최근 본 자료
댓글(0)
0